Less time wasted on side-effects disclosures and disclaimers and more time to sing the praises of its viability. I was wondering the same thing in regards to the REMS evaluation. Have there been any report of side-effects serious enough that would need to be addressed in the company's strategy? Seems like there were a few reporting nausea or headaches from the initial round of e-IND treatments. I've got a good feeling we'll come out on top when the patient looks at the warning labels and has to choose between a treatment that may cause liver damage and one that may require a shot of Maalox or a couple ibuprofen. Stand down BP!!

(Les)Claypool-(Sean)Lennon Delirium band has a cool song about the pharm industry and side effects. Or Psyde-effects as they phrase it.